Aplastic Anemia [clinicaltrials_resource:7a638b06322ae0f69efab2c34213005f]
Collection of Blood From Patients With Pancytopenia [clinicaltrials:NCT00001214]Stem Cell Factor Medication for Aplastic Anemia [clinicaltrials:NCT00001398]clinicaltrials:NCT00001626Collection of Blood and Bone Marrow From Healthy Volunteers and Patients for Research Purposes [clinicaltrials:NCT00001627]clinicaltrials:NCT00001962Phase II Study of Bone Marrow Transplantation Using Related Donors in Patients With Aplastic Anemia [clinicaltrials:NCT00004323]Study of High Dose Cyclophosphamide in Patients With Severe Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria [clinicaltrials:NCT00004464]Phase III Randomized Study of Cyclophosphamide With or Without Antithymocyte Globulin Before Bone Marrow Transplantation in Patients With Aplastic Anemia [clinicaltrials:NCT00004474]Mycophenolate Mofetil and Cyclosporine to Treat Relapsing Aplastic Anemia [clinicaltrials:NCT00005935]Oral Manifestations of Aplastic Anemia [clinicaltrials:NCT00006300]Protection Against Benzene Toxicity [clinicaltrials:NCT00011453]Stem Cell Mobilization Potential in Patients With Aplastic Anemia in Remission [clinicaltrials:NCT00011830]Study of Allogeneic Bone Marrow and T-Cell Depleted, CD34+ Peripheral Blood Stem Cell Transplantation in Patients With Aplastic Anemia [clinicaltrials:NCT00017654]Cancer in Inherited Bone Marrow Failure Syndromes [clinicaltrials:NCT00027274]Blood Transplantation for Patients With Hematologic Malignancies or Bone Marrow Failure States [clinicaltrials:NCT00038779]Collection of Biological Samples From Patients With Hepatitis-Associated Aplastic Anemia [clinicaltrials:NCT00050115]clinicaltrials:NCT00061360clinicaltrials:NCT00065260Purified CD34+ Hematopoietic Stem Cell Transplantation From Alternate Donors for Patients With Severe Aplastic Anemia [clinicaltrials:NCT00186797]Cyclophosphamide and Anti-thymocyte Globulin Followed By Methotrexate and Cyclosporine in Preventing Chronic Graft-Versus-Host Disease in Patients With Severe Aplastic Anemia Undergoing Donor Bone Marrow Transplant [clinicaltrials:NCT00343785]clinicaltrials:NCT00354419Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant and Cyclophosphamide, Mycophenolate Mofetil, Tacrolimus, and Sirolimus in Treating Patients With Primary Immunodeficiency Disorders or Noncancerous Inherited Disorders [clinicaltrials:NCT00358657]clinicaltrials:NCT00427336clinicaltrials:NCT00455312clinicaltrials:NCT00471848clinicaltrials:NCT00474747Non-Myeloablative Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Treatment of Hematologic Malignancies, Renal Cell Carcinoma, and Aplastic Anemia [clinicaltrials:NCT00513175]Nonmyeloablative Allogeneic Stem Cell Transplantation From HLA-Matched Unrelated Donor for the Treatment of Hematologic Disorders [clinicaltrials:NCT00533923]clinicaltrials:NCT00556400Investigation of the Cylex® ImmuKnow® Assay [clinicaltrials:NCT00569842]clinicaltrials:NCT00578903Nonmyeloablative Allo SCT for the Treatment of Hematologic Disorders [clinicaltrials:NCT00636909]clinicaltrials:NCT00673114A Phase II Study of Umbilical Cord Blood Transplantation [clinicaltrials:NCT00676806]Neuropsychological Effects of Immunosuppressive Treatment in Subjects With Aplastic Anemia [clinicaltrials:NCT00767650]clinicaltrials:NCT00806598Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Disorders [clinicaltrials:NCT00856388]Study of Fludarabine + Cyclophosphamide + TBI Conditioning Regimen for Double Units Cord Blood Transplantation(CBT)in Severe Aplastic Anemia(SAA) [clinicaltrials:NCT00881933]Reduced Toxicity Fludarabine (Flu) + Cyclophosphamide (CPM) + Rabbit Antithymocyte Globulin (rATG) Conditioning Regimen for Unrelated Donor Transplantation in Severe Aplastic Anemia (SAA) [clinicaltrials:NCT00882323]clinicaltrials:NCT00987480
condition [clinicaltrials_vocabulary:condition]
exclusion criteria [clinicaltrials_vocabulary:exclusion-criteria]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
Aplastic Anemia [clinicaltrials_resource:7a638b06322ae0f69efab2c34213005f]
Bio2RDF identifier
7a638b06322ae0f69efab2c34213005f
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:7a638b06322ae0f69efab2c34213005f
identifier
clinicaltrials_resource:7a638b06322ae0f69efab2c34213005f
title
Aplastic Anemia
@en
label
Aplastic Anemia [clinicaltrials_resource:7a638b06322ae0f69efab2c34213005f]
@en